Pay in 4 interest-free payments of $28.26 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
and significance attributed to thin hazes of bacterial survival
KRAS WT model
Nupercainal hydrochloride
PubMed PMID: 27696405
is a potent helicase primase inhibitor
PHA-848125 - CAS# 802539-81-7 Catalog No.:M10691-10 and significance attributed to thinMilciclib, also known as PHA 848125 or PHA 848125AC, is an orally bioavailable inhibitor of cyclin dependent kinases (CDKs) and thropomyosin receptor kinase A (TRKA), with potential antineoplastic activity. CDK2 TRKA inhibitor PHA 848125 AC potently inhibits cyclin dependent kinase 2 (CDK2) and exhibits activity against other CDKs including CDK1 and CDK4, in addition to TRKA. Inhibition of these kinases may result in cell cycle arrest and apoptosis of
US$ 399.19
US$ 173.25
US$ 518.00
US$ 207.90
US$ 147.58
US$ 792.00
US$ 207.90
US$ 109.60
US$ 126.47
US$ 117.30
US$ 188.90
US$ 141.26
US$ 319.63
US$ 188.90
US$ 141.26
US$ 352.00
US$ 328.83
US$ 438.44